Every SEC Form 3/4/5 on record for this filer (CIK 1801061) — 1 issuer, 125 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics, Inc. | See Remarks · Director | 2020-01-30 → 2026-05-06 | 69 | −$9M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ARQT | 2026-05-04 | Sell | 3,172 | $23.61 | $74,891 | 720,755 |
| ARQT | 2026-03-02 | Sell | 36,281 | $25.16 | $912,830 | 787,025 |
| ARQT | 2026-03-02 | Sell | 1,068 | $25.91 | $27,672 | 785,957 |
| ARQT | 2026-02-02 | Sell | 19,833 | $25.50 | $505,742 | 721,306 |
| ARQT | 2025-11-24 | Sell | 48,945 | $30.36 | $1M | 740,537 |
| ARQT | 2025-11-21 | Sell | 1,055 | $30.00 | $31,650 | 793,838 |
| ARQT | 2025-11-03 | Sell | 69 | $25.40 | $1,753 | 794,893 |
| ARQT | 2025-11-03 | Sell | 11,478 | $24.71 | $283,621 | 794,962 |
| ARQT | 2025-10-28 | Sell | 40,000 | $25.03 | $1M | 806,440 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.
